PATHOLOGIC STAGE IIB CUTANEOUS MELANOMA AJCC V8
Clinical trials for PATHOLOGIC STAGE IIB CUTANEOUS MELANOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PATHOLOGIC STAGE IIB CUTANEOUS MELANOMA AJCC V8 trials appear
Sign up with your email to follow new studies for PATHOLOGIC STAGE IIB CUTANEOUS MELANOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Facebook groups fight skin cancer in families
Prevention OngoingThis study is testing whether private Facebook groups can help young melanoma survivors and their close family members prevent future skin cancer. Researchers are comparing two types of groups: one focused on skin cancer education and one on general healthy living. The goal is to…
Matched conditions: PATHOLOGIC STAGE IIB CUTANEOUS MELANOMA AJCC V8
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Prevention
Last updated Mar 30, 2026 14:34 UTC
-
Common heart pill could block deadly skin cancer spread
Prevention OngoingThis study is testing whether atorvastatin, a drug commonly used to lower cholesterol, can prevent melanoma skin cancer from spreading (metastasizing) in people who have had it surgically removed but are at high risk of it returning. About 150 participants who have had surgery fo…
Matched conditions: PATHOLOGIC STAGE IIB CUTANEOUS MELANOMA AJCC V8
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Prevention
Last updated Mar 27, 2026 12:39 UTC
-
Cancer surgery antibiotics: a hidden gut microbe mystery
Knowledge-focused OngoingThis study aims to understand how a common antibiotic given right before surgery affects the community of bacteria in the gut (the microbiome) of patients with early-stage skin cancer (melanoma). Researchers will compare patients who receive the antibiotic to those who do not, ch…
Matched conditions: PATHOLOGIC STAGE IIB CUTANEOUS MELANOMA AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC